- What is Incyte Genomics Inc's Market Cap?
- Incyte Genomics Inc's Market Cap is $23.4B, based on as-reported figures from SEC (XBRL) filings.
- What is Incyte Genomics Inc's Enterprise Value?
- Incyte Genomics Inc's Enterprise Value is $20.1B, based on as-reported figures from SEC (XBRL) filings.
- What is Incyte Genomics Inc's Trailing P/E?
- Incyte Genomics Inc's Trailing P/E is 57.9×, based on as-reported figures from SEC (XBRL) filings.
- What is Incyte Genomics Inc's Price / Sales?
- Incyte Genomics Inc's Price / Sales is 3.9×, based on as-reported figures from SEC (XBRL) filings.
- What is Incyte Genomics Inc's EV / Revenue?
- Incyte Genomics Inc's EV / Revenue is 3.3×, based on as-reported figures from SEC (XBRL) filings.
- What is Incyte Genomics Inc's EV / EBITDA?
- Incyte Genomics Inc's EV / EBITDA is 27.8×, based on as-reported figures from SEC (XBRL) filings.
- What is Incyte Genomics Inc's Revenue (TTM)?
- Incyte Genomics Inc's Revenue (TTM) is $6.0B, based on as-reported figures from SEC (XBRL) filings.
- What is Incyte Genomics Inc's Net Income (TTM)?
- Incyte Genomics Inc's Net Income (TTM) is $403.4M, based on as-reported figures from SEC (XBRL) filings.
- What is Incyte Genomics Inc's EBITDA?
- Incyte Genomics Inc's EBITDA is $724.9M, based on as-reported figures from SEC (XBRL) filings.
- What is Incyte Genomics Inc's Diluted EPS (TTM)?
- Incyte Genomics Inc's Diluted EPS (TTM) is 1.98, based on as-reported figures from SEC (XBRL) filings.